Search Results 651-660 of 16019 for Residual
The data collected from this study will help facilitate research on proton beam radiation therapy and allow for collaborative research. The PPCR will collect ...
Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the ...
residual type B after repair of a type A are low, but up to 80% of these patients will experience aneurysmal degeneration of their remaining dis- sected ...
Nasopharyngeal carcinoma is cancer that happens in the nasopharynx, which sits behind the nose and above the back of the throat.
placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.
"Mary has an extremely short residual limb. That poses difficulty with being able to fit her with the socket. So. Mary has had constant problems." Physicians ...
imb loss, Phantom pain, Residual limb pain. Show more areas of focus for Fantley C. Smither, M.D.. Brittany Snider, D.O.. Physiatrist.
Rochester, Minn. The purpose of this study is to evaluate the overall minimal residual disease (MRD) negative rate of participants who receive JNJ-68284528.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.